Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: ECOG-ACRIN Cancer Research Group
Condition: Kidney Cancer
NCT01164228
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.